PARP inhibitor Iniparib, Purity ≥98%

Synonym: 160003-66-7; 4-Iodo-3-nitrobenzamide; Iniparib; BSI-201; Iniparib (BSI-201); BSI 201; 4-Iodo-3-nitro-Benzamide; 4-oxo-1,4-Dihydro-quinoline-6-carboxylicacid; PARP inhibitor

MDL: MFCD11110639
CAS Number: 160003-66-7
Compound CID: 9796068

Product Size

10 mg; 25 mg; 50 mg; 100 mg; 200 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Iniparib, soluble in DMSO and ethanol and insoluble in water, binds to the PARP enzyme's active site, preventing it from repairing single-strand DNA breaks. It targets PARP1.

Molecular Weight

292

Molecular Formula

C₇H₅IN₂O₃

Targets

PARP1

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 53 mg/mL (181.48 mM); Water: Insoluble; Ethanol: 25 mg/mL (85.61 mM)

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Iniparib can be used to study its function as a PARP inhibitor in cancer therapy research.

Storage

Store at -20ºC.